Exact Sciences Stock Alpha and Beta Analysis

EXAS Stock  USD 56.84  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as EXACT Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in EXACT Sciences over a specified time horizon. Remember, high EXACT Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to EXACT Sciences' market risk premium analysis include:
Beta
(0.27)
Alpha
(0.14)
Risk
3.87
Sharpe Ratio
(0.04)
Expected Return
(0.16)
Please note that although EXACT Sciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, EXACT Sciences did 0.14  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of EXACT Sciences stock's relative risk over its benchmark. EXACT Sciences has a beta of 0.27  . As returns on the market increase, returns on owning EXACT Sciences are expected to decrease at a much lower rate. During the bear market, EXACT Sciences is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out EXACT Sciences Backtesting, EXACT Sciences Valuation, EXACT Sciences Correlation, EXACT Sciences Hype Analysis, EXACT Sciences Volatility, EXACT Sciences History and analyze EXACT Sciences Performance.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

EXACT Sciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. EXACT Sciences market risk premium is the additional return an investor will receive from holding EXACT Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in EXACT Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate EXACT Sciences' performance over market.
α-0.14   β-0.27

EXACT Sciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of EXACT Sciences' Buy-and-hold return. Our buy-and-hold chart shows how EXACT Sciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

EXACT Sciences Market Price Analysis

Market price analysis indicators help investors to evaluate how EXACT Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading EXACT Sciences shares will generate the highest return on investment. By understating and applying EXACT Sciences stock market price indicators, traders can identify EXACT Sciences position entry and exit signals to maximize returns.

EXACT Sciences Return and Market Media

The median price of EXACT Sciences for the period between Fri, Sep 20, 2024 and Thu, Dec 19, 2024 is 67.94 with a coefficient of variation of 11.04. The daily time series for the period is distributed with a sample standard deviation of 7.06, arithmetic mean of 63.96, and mean deviation of 6.03. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Is EXAS Stock a Smart Addition to Your Portfolio Right Now
10/04/2024
2
Stifel Nicolaus Has Lowered Expectations for Exact Sciences Stock Price
11/07/2024
3
Acquisition by Kevin Conroy of 19500 shares of EXACT Sciences at 51.35 subject to Rule 16b-3
11/13/2024
4
EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test
11/18/2024
5
Swiss National Bank Increases Holdings in Exact Sciences Co. - MarketBeat
11/21/2024
6
Acquisition by Kevin Conroy of 102837 shares of EXACT Sciences at 13.96 subject to Rule 16b-3
11/26/2024
7
Acquisition by Orville Jacob A of 4724 shares of EXACT Sciences subject to Rule 16b-3
12/02/2024
8
Acquisition by Orville Jacob A of 2034 shares of EXACT Sciences subject to Rule 16b-3
12/03/2024
9
IHT Wealth Management LLC Invests 305,000 in Exact Sciences Co.
12/10/2024
10
Geode Capital Management LLC Buys 7,873 Shares of Exact Sciences Co.
12/16/2024

About EXACT Sciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including EXACT or other stocks. Alpha measures the amount that position in EXACT Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

EXACT Sciences Upcoming Company Events

As portrayed in its financial statements, the presentation of EXACT Sciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, EXACT Sciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of EXACT Sciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of EXACT Sciences. Please utilize our Beneish M Score to check the likelihood of EXACT Sciences' management manipulating its earnings.
20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with EXACT Sciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.